FOXO3 and breast carcinoma: In vitro and in vivo studies on tamoxifen-resistant breast cancer cells showed that the tamoxifen-resistant cells had low levels of FoxO3a, a protein that regulates cell growth and death, which was linked to their resistance to tamoxifen.